ResMed dismisses KPMG, appoints PwC; Carol Burt to become Lead Director

RESMED INC

KPMG dismissed as auditor Aug 13, 2026; PwC appointed for FY2027 subject to client acceptance.
No disagreements or reportable events with KPMG; KPMG letter filed as Exhibit 16.1.
Ron Taylor to retire after 21 years; not standing for reelection at Nov 18, 2026 annual meeting.
Carol Burt to become Lead Director effective Nov 15, 2026; on board since 2013, chairs Nominating and Governance.

item 4.01 item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Carol Burt

Lead Director

RMD · RESMED INC

Effective: 2026-11-15
Filed: August 17, 2026, 4:30 PM ET

the Board approved the appointment of Carol Burt as lead director, effective November 15, 2026.

Departed

Ronald Taylor

Director

RMD · RESMED INC

Effective: 2026-11-18
Filed: August 17, 2026, 4:30 PM ET

On August 13, 2026, Ronald Taylor, a director of Resmed, informed the Board that he will not stand for election at Resmed’s 2026 annual meeting of stockholders (the “Annual Meeting”) and intends to retire from the Board, effective at the Annual Meeting, which is expected to be held on November 18, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Carol Burt was appointed as Lead Director at RESMED INC.

Action: appointed
Role: Lead Director

Exact text from the filing

the Board approved the appointment of Carol Burt as lead director, effective November 15, 2026.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Ronald Taylor departed as Director at RESMED INC.

Action: retire
Role: Director

Exact text from the filing

On August 13, 2026, Ronald Taylor, a director of Resmed, informed the Board that he will not stand for election at Resmed’s 2026 annual meeting of stockholders (the “Annual Meeting”) and intends to retire from the Board, effective at the Annual Meeting, which is expected to be held on November 18, 2026.

View on SEC.gov

RESMED INC filing history →

Source: SEC EDGAR

accession 0001193125-26-354154

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.